Sort
51,593 grants matching “hepatitis”
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$820,281University Of Louisiana At Lafayette · U42 · FY2000 · RR
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
$819,876University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · DK
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$819,282University Of Louisiana At Lafayette · U42 · FY2001 · RR
Glucose patterns and clinical outcomes in the Dallas Heart Study: A pathway to precision diabetes
$819,091Elizabeth Selvin · Johns Hopkins University · R01 · FY2025 · DK
Asian Community Cancer Health Disparities Center (ACCHDC)
$818,899Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2013 · CA
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies
$818,748Bryan Lau · Johns Hopkins University · R01 · FY2022 · AI
Improving Hepatitis C Treatment in Injection Drug Users
$818,555Upstate Medical University · R01 · FY2004 · DA
Ultrasound-Mediated Gene Therapy for Hemophilia B
$818,532Carol H Miao · Seattle Children'S Hospital · R33 · FY2011 · HL
HBV cccDNA transcriptional silencing with and without HIV
$818,465Ashwin Balagopal · Johns Hopkins University · R01 · FY2025 · AI
A Multi-Center Study of Acute Liver Failure in Adults
$818,431William M Lee · Ut Southwestern Medical Center · U01 · FY2009 · DK
Inhibitors and Probes of HIV-1 Cell Fusion
$818,419Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Role of the nsP3 macrodomain in alphavirus virulence
$818,095Diane E Griffin · Johns Hopkins University · R56 · FY2019 · AI
Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling
$817,729Nana Kwaku Minkah · Seattle Children'S Hospital · R01 · FY2023 · AI
Intensive Models of HCV Care for Injection Drug Users
$817,702Alain Litwin · Albert Einstein College Of Medicine · R01 · FY2012 · DA
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
$817,644Andrea L Cox · Johns Hopkins University · U19 · FY2021 · AI
Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection
$817,262Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2022 · AG
T Cell Differentiation
$817,244B. Fowlkes · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Pharmacogenetics of the Statin Response
$817,001Ernst John Schaefer · Tufts University Boston · R01 · FY2006 · HL
Center for Metabolic Research on HIV and Drug Use
$816,761Sherwood L Gorbach · Tufts University Boston · P30 · FY2011 · DA
Cancer Risk in Human Populations
$816,676Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury
$816,664Eytan R Barnea · Bioincept, Llc · R44 · FY2025 · HD
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$816,553Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2018 · GM
Antisense Mediated Treatment of Hepatitis B Virus Infection
$816,540Stefan Frank Wieland · Scripps Research Institute, The · R01 · FY2011 · AI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors
$816,195Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2018 · AI
RISK FACTORS FOR AIDS AMONG IV DRUG USERS
$816,190Beth Israel Medical Ctr (New York) · R01 · FY2003 · DA